Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Characterization of single lesion nonfunctioning pancreatic neuroendocrine carcinoma via computed tomography.

Hu J, Hu Q, Hu H.

Oncol Lett. 2017 Apr;13(4):2186-2190. doi: 10.3892/ol.2017.5729. Epub 2017 Feb 13.

2.

Correlates associated with participation in physical activity among adults: a systematic review of reviews and update.

Choi J, Lee M, Lee JK, Kang D, Choi JY.

BMC Public Health. 2017 Apr 24;17(1):356. doi: 10.1186/s12889-017-4255-2.

3.

Prevention of tumorigenesis in mice by exercise is dependent on strain background and timing relative to carcinogen exposure.

Kelly SA, Zhao L, Jung KC, Hua K, Threadgill DW, Kim Y, de Villena FP, Pomp D.

Sci Rep. 2017 Feb 22;7:43086. doi: 10.1038/srep43086.

4.

Proton pump inhibitors on pancreatic cancer risk and survival.

Kearns MD, Boursi B, Yang YX.

Cancer Epidemiol. 2017 Feb;46:80-84. doi: 10.1016/j.canep.2016.12.006. Epub 2017 Jan 2.

PMID:
28056391
5.

Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.

Andersson G, Wennersten C, Borgquist S, Jirström K.

Biol Sex Differ. 2016 Dec 9;7:66. eCollection 2016.

6.

Obesity-Related Digestive Diseases and Their Pathophysiology.

Nam SY.

Gut Liver. 2017 May 15;11(3):323-334. doi: 10.5009/gnl15557. Review.

7.

Pancreatic Cancer: A Survival Analysis Study in Oklahoma.

Wahutu M, Vesely SK, Campbell J, Pate A, Salvatore AL, Janitz AE.

J Okla State Med Assoc. 2016 Jul-Aug;109(7-8):391-398.

8.

Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.

Babic A, Bao Y, Qian ZR, Yuan C, Giovannucci EL, Aschard H, Kraft P, Amundadottir LT, Stolzenberg-Solomon R, Morales-Oyarvide V, Ng K, Stampfer MJ, Ogino S, Buring JE, Sesso HD, Gaziano JM, Rifai N, Pollak MN, Anderson ML, Cochrane BB, Luo J, Manson JE, Fuchs CS, Wolpin BM.

Cancer Res. 2016 Dec 15;76(24):7160-7167. Epub 2016 Oct 25.

PMID:
27780823
9.

Physical activity and the incidence of multiple sclerosis.

Dorans KS, Massa J, Chitnis T, Ascherio A, Munger KL.

Neurology. 2016 Oct 25;87(17):1770-1776. Epub 2016 Sep 28.

PMID:
27683852
10.

Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.

Catanzaro R, Cuffari B, Italia A, Marotta F.

World J Gastroenterol. 2016 Sep 14;22(34):7660-75. doi: 10.3748/wjg.v22.i34.7660. Review.

11.

NO and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

Wang J, Hussain SP.

Antioxid Redox Signal. 2017 Jun 10;26(17):1000-1008. doi: 10.1089/ars.2016.6809. Epub 2016 Sep 22.

PMID:
27510096
12.

Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Birmann BM, Barnard ME, Bertrand KA, Bao Y, Crous-Bou M, Wolpin BM, De Vivo I, Tworoger SS.

Am J Public Health. 2016 Sep;106(9):1608-15. doi: 10.2105/AJPH.2016.303337. Epub 2016 Jul 26. Review.

13.

Influence of Body Mass Index and Albumin on Perioperative Morbidity and Clinical Outcomes in Resected Pancreatic Adenocarcinoma.

Hendifar A, Osipov A, Khanuja J, Nissen N, Naziri J, Yang W, Li Q, Tuli R.

PLoS One. 2016 Mar 25;11(3):e0152172. doi: 10.1371/journal.pone.0152172. eCollection 2016.

14.

Noninvasive urinary miRNA biomarkers for early detection of pancreatic adenocarcinoma.

Debernardi S, Massat NJ, Radon TP, Sangaralingam A, Banissi A, Ennis DP, Dowe T, Chelala C, Pereira SP, Kocher HM, Young BD, Bond-Smith G, Hutchins R, Crnogorac-Jurcevic T.

Am J Cancer Res. 2015 Oct 15;5(11):3455-66. eCollection 2015.

15.

Rare long-term survivors of pancreatic adenocarcinoma without curative resection.

Oh SY, Edwards A, Mandelson MT, Lin B, Dorer R, Helton WS, Kozarek RA, Picozzi VJ.

World J Gastroenterol. 2015 Dec 28;21(48):13574-81. doi: 10.3748/wjg.v21.i48.13574.

16.

Evaluation of a Self-Administered Computerized Cognitive Battery in an Older Population.

Koyama AK, Hagan KA, Okereke OI, Weisskopf MG, Rosner B, Grodstein F.

Neuroepidemiology. 2015;45(4):264-72. doi: 10.1159/000439592. Epub 2015 Oct 27.

17.

Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.

Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, Giles GG, Hartge P, Singh PN, Stolzenberg-Solomon RZ, Weiderpass E, Adami HO, Anderson KE, Beane-Freeman LE, Buring JE, Fraser GE, Fuchs CS, Gapstur SM, Gaziano JM, Helzlsouer KJ, Lacey JV Jr, Linet MS, Liu JJ, Park Y, Peters U, Purdue MP, Robien K, Schairer C, Sesso HD, Visvanathan K, White E, Wolk A, Wolpin BM, Zeleniuch-Jacquotte A, Jacobs EJ.

Ann Oncol. 2015 Nov;26(11):2257-66. doi: 10.1093/annonc/mdv355. Epub 2015 Sep 7. Review.

18.

Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma.

Stolzenberg-Solomon RZ, Amundadottir LT.

Hematol Oncol Clin North Am. 2015 Aug;29(4):619-40. doi: 10.1016/j.hoc.2015.04.009. Review.

19.

Overweight increases the risk of malignancy in patients with pancreatic mucinous cystic neoplasms.

Chang YT, Tien YW, Jeng YM, Yang CY, Liang PC, Wong JM, Chang MC.

Medicine (Baltimore). 2015 May;94(20):e797. doi: 10.1097/MD.0000000000000797.

20.

MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.

Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S, Chen J.

PLoS One. 2015 Apr 9;10(4):e0119783. doi: 10.1371/journal.pone.0119783. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128257.

Supplemental Content

Support Center